Paul Hastings Reps Korean Drug Co. In $126M GSK Deal
GlaxoSmithKline PLC announced Tuesday it would pay KRW142.9 billion ($125.9 million) for a stake in South Korean drugmaker Dong-A Pharmaceuticals Co. Ltd., in an effort to expand into the Asian pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article